MicroQuin: hunting down breast cancer

Working with two complementary technologies, biotech company MicroQuin is developing next-generation targeted therapies that kill all breast cancers with no toxicity.

Like Comment
Page of
Go to the profile of Microquin


Founded in London (United Kingdom) in 2016, MicroQuin was born out of a collaborative and inclusive approach to research. MicroQuin is a biotechnology, R&D based company currently focusing on developing therapeutics to address a range of oncological disease. MicroQuin is progressing lead compounds into clinical trials, which offer a potential cure to Breast Cancer and other diseases.

No comments yet.